Novosanis NV
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Subsidiary
- Established
- 2013-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.novosanis.com
Investigation of Urinary Biomarkers for the Detection of Prostate Cancer
Not Applicable
Withdrawn
- Conditions
- Liquid BiopsyProstate CancerUrine
- Interventions
- Device: Colli-Pee UAS devices
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Novosanis NV
- Registration Number
- NCT05454371
- Locations
- 🇧🇪
Universitair ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium
Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications
Not Applicable
Active, not recruiting
- Conditions
- Prostate CancerLiquid BiopsyBreast CancerUrine
- Interventions
- Device: Colli-Pee UAS devices
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Novosanis NV
- Target Recruit Count
- 105
- Registration Number
- NCT05453604
- Locations
- 🇧🇪
Universitair ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium
Investigation of Urinary Biomarkers for the Detection of Breast Cancer
Not Applicable
Recruiting
- Conditions
- UrineBreast CancerLiquid Biopsy
- Interventions
- Device: Colli-Pee UAS devices
- First Posted Date
- 2022-07-12
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- Novosanis NV
- Target Recruit Count
- 200
- Registration Number
- NCT05453591
- Locations
- 🇧🇪
Universitair ziekenhuis Antwerpen, Edegem, Antwerpen, Belgium
Echographic Measurement of Skin Thickness in Children
Completed
- Conditions
- Skin Thickness
- Interventions
- Other: Echographic measurement of skin thickness
- First Posted Date
- 2016-04-04
- Last Posted Date
- 2017-09-21
- Lead Sponsor
- Novosanis NV
- Target Recruit Count
- 259
- Registration Number
- NCT02727114
- Locations
- 🇧🇪
University of Antwerp, Wilrijk, Antwerp, Belgium
🇧🇪Child & Family (Dutch: Kind&Gezin) Antwerp, Antwerp, Belgium
🇧🇪primary and secundary schools in Antwerp, Belgium, Antwerp, Belgium
Echographic Measurement of Skin Thickness
Completed
- Conditions
- Skin Thickness
- Interventions
- Other: Echographic measurement of skin thickness
- First Posted Date
- 2015-02-16
- Last Posted Date
- 2015-10-06
- Lead Sponsor
- Novosanis NV
- Target Recruit Count
- 100
- Registration Number
- NCT02363465
- Locations
- 🇧🇪
Department of Pharmaceutical Sciences; Laboratory of Physiopharmacology; University of Antwerp; Campus Drie Eiken, Wilrijk, Antwerp, Belgium
Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID
Phase 1
Completed
- Conditions
- Hepatitis B
- Interventions
- Device: VAX-IDDrug: 1.0 cc HBVAXPRO 10mcgr/ml (Sanofi Pasteur MSD)Drug: 0.1cc HBVAXPRO 40mcgr/ml (Sanofi Pasteur MSD)
- First Posted Date
- 2014-07-10
- Last Posted Date
- 2017-03-28
- Lead Sponsor
- Novosanis NV
- Target Recruit Count
- 48
- Registration Number
- NCT02186977
- Locations
- 🇧🇪
Centre for the Evaluation of Vaccination Vaccine & Infectious Disease Institute, Wilrijk, Antwerp, Belgium
© Copyright 2025. All Rights Reserved by MedPath